Epidemiology - The REACT Programme
- Funded by UK Research and Innovation (UKRI)
- Total publications:0 publications
Grant number: C19-IUC-273
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
UK Research and Innovation (UKRI)Principal Investigator
Prof. Paul ElliottResearch Location
United KingdomLead Research Institution
UK Dementia Research InstituteResearch Priority Alignment
N/A
Research Category
Epidemiological studiesResearch Subcategory
Disease transmission dynamicsSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Not applicableBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
The REACT programme, the largest of its kind, is a series of studies that are monitoring how the COVID-19 virus is spreading across England. Commissioned by the Department of Health and Social Care, the REACT series of studies are being carried out in partnership with Imperial College Healthcare NHS Trust and Ipsos MORI. The research is offering insight into infection rates broken down by geography, age, sex, ethnicity, key worker status and symptoms. REACT is the largest study of its kind and offers a comprehensive approach to antigen and antibody testing including a large sample (5000+) of keyworkers. REACT 1 and REACT 2 participants are to be followed up via NHS records. Patients who tested positive for COVID-19 (either antigen or antibody) will be followed up for neurological diseases via NHS records.